The epidemiological trends of Biliary tract cancers in United States

Author:

Jiang Yong1,Jiang Liyong1,Li Feiyu1,Li Qingbin2,Yuan Shuai1,Huang Songhan1,Yan Xiangyu1,Chen Ji2,Fu Yingda1,Li Hongxin1,Li Shenhao1,Liu Jun1

Affiliation:

1. Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University

2. Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University

Abstract

Abstract Background: Biliary tract cancers (BTCs) are a series of heterogeneous malignancies that are broadly grouped based on the anatomical site where they arise into subtypes including intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), gallbladder cancer (GBC), and ampulla of Vater cancer (AVC).Methods and Results: The present study serves to provide an overview of the epidemiology of various biliary tract cancers (BTCs) based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database from 2000-2018. Differences in both incidence and mortality rates were observed for these distinct BTCs as a function of age, sex, ethnicity, and calendar year. In 2018, BTCs emerged as the 5th most prevalent form of alimentary tract cancer in US. While increasing trends were observed with respect to ICC incidence and associated mortality, the rates of GBC, ECC, and AVC have remained stable, as have the corresponding mortality rates. The most common and deadliest BTCs in 2018 were ICC and GBC among males and females, respectively. The ethnic groups exhibiting the highest incidence rates of these different BTCs were Black individuals for GBC, Asian and Pacific Islanders for ECC and AVC, and White or Asian and Pacific Islanders for ICC. The incidence of all of these forms of BTC rose with age. There were a few changes among BTCs in staging, locoregional surgical treatments, adjuvant therapies, and prognostic outcomes from 2000-2018.Conclusions: The epidemiological characteristics, staging, locoregional surgical treatments, adjuvant therapies, and prognostic outcomes were distinct for each of these BTCs.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3